Corporate Profile

Webcast ImageWebcast
Teleflex Incorporated at J.P. Morgan Healthcare Conference (Replay)
01/10/17 at 9:00 a.m. PT
Teleflex Incorporated at J.P. Morgan Healthcare Conference
Tuesday, January 10, 2017 9:00 a.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Teleflex is a global provider of medical technology products that enhance clinical benefits, improve patient and provider safety and reduce total procedural costs. To achieve this mission, Teleflex is committed to the following: investing in technology and developing our pipeline; leveraging and building our core franchises and distribution channels; attracting, developing and retaining talented employees around the world; and continuing to build financial strength by expanding our margins and maintaining strong cash flow all in an effort to successfully grow our reputation as a solid investment and a profitable, strong employer. We primarily design, develop, manufacture and supply single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. We sell our products to hospitals and healthcare providers worldwide through a combination of our direct sales force and distributors. Our products are used in a wide variety of markets and are not dependent upon any one end-market or procedure.

We are focused on achieving consistent , sustainable and profitable growth by increasing our market share and improving operating efficiencies through:

  • • the development of new products and product line extensions;

  • • the investment in new technologies and broadening their applications;

  • • the expansion of the use of existing products in existing markets, as well as in new geographic markets;

  • • leveraging our direct sales force and distribution network with new products, manufacturing and distribution facility rationalization and achieving economies of scale as we continue to expand; and

  • • the potential broadening of our product portfolio through select acquisitions, licensing arrangements and partnerships that enhance, extend or expedite our development initiatives or our ability to increase our market share.
 
Recent NewsMore »
01/10/17
Teleflex (TFX) Receives FDA 510(k) Clearance for its Arrow® VPS Rhythm™ Device with Optional TipTracker™ Technology
510(k) Clearance for the Arrow® VPS Rhythm™ Device expands Teleflex’s Catheter Tip Navigation and Placement portfolio to now include familiar ECG-only technology for the elimination of chest X-ray WAYNE, Pa.--(BUSINESS WIRE)--Jan. 10, 2017-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced that its Arrow® VPS Rhythm™ Device with Optional TipTracker™ Technology has... 
01/10/17
Teleflex Launches the LMA® Gastro™ Airway for Airway Management During Endoscopic Procedures
Global airway management provider launches innovative technology to address airway management challenges associated with endoscopic procedures. The LMA® Gastro™ Airway is the first laryngeal mask designed specifically to facilitate esophageal access and promote airway control during endoscopic procedures. WAYNE, Pa.--(BUSINESS WIRE)--Jan. 10, 2017-- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technolog... 
12/27/16
Teleflex to Present at the 35th Annual J.P. Morgan Healthcare Conference
WAYNE, Pa.--(BUSINESS WIRE)--Dec. 27, 2016-- Benson F. Smith, Chairman and CEO, Teleflex Incorporated (NYSE:TFX), is scheduled to speak at the 35th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, California, on Tuesday, January 10, 2017 at 9:00 a.m. (PT). A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor portion o... 
12/15/16
Teleflex Enters Into Separate Privately Negotiated Agreements with Certain of its Convertible Note Holders
WAYNE, Pa.--(BUSINESS WIRE)--Dec. 15, 2016-- Teleflex Incorporated (NYSE:TFX) announced today that it has entered into separate, privately negotiated agreements with certain of the holders of its 3.875% convertible senior subordinated notes due 2017 (the “Notes”). Teleflex has agreed to exchange approximately $91.7 million aggregate principal amount of the Notes for cash in an amount equal to $1,000 per $1,000 principal amount of Notes, a number of share... 
 
Upcoming EventsMore »
There are currently no events scheduled.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.


Print Page Print Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet